MapLight Therapeutics, Inc. MPLT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's investing cash flow?
- MapLight Therapeutics, Inc. (MPLT) reported investing cash flow of $67.01M in Q1 2026.
- How has MapLight Therapeutics, Inc. 's investing cash flow changed year-over-year?
- MapLight Therapeutics, Inc. 's investing cash flow increased by 78.7% year-over-year, from $37.5M to $67.01M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.